Harmony Biosciences Holdings Inc Revenue per Employee (HRMY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Harmony Biosciences Holdings inc   (NASDAQ: HRMY)
 

Harmony Biosciences Holdings Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 30.42% in the second quarter 2026, year on year to cumulative value of $960 million, Harmony Biosciences Holdings Inc 's revenue per employee grew on a trailing twelve months basis to $ 3,277,102. The productivity of Harmony Biosciences Holdings Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 20 other companies have achieved higher revenue per employee. While Harmony Biosciences Holdings Inc 's total ranking has deteriorated compared to the previous quarter from 207 to 292. Harmony Biosciences Holdings Inc has 293 employees.


What is Sales per Employee Ratio?







HRMY Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 30.42 % 16.95 % 21.49 % 28.9 % 16.02 %
Sales per Employee (TTM) $ 3,277,102 3,069,102 2,962,836 2,814,805 2,632,058
HRMY's Total Ranking # 292 # 207 # 222 # 183 # 281
Seq. Revenue Change 21.6 % -12.38 % 2.69 % 19.2 % 9.03 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 13
Healthcare Sector # 21
Overall Market # 292

Revenue per Employee Statistics
High Average Low
$ 3,069,102 $ 1,796,583 $ 155,662
(Mar 31 2026)   (Sep 30 2020)



Financial Statements
Harmony Biosciences Holdings Inc 's Revenue MRQ $ 261 Millions Visit HRMY's Income Statement
Harmony Biosciences Holdings Inc 's Revenues TTM $ 960 Millions Visit HRMY's aggregate revenue growth
What are HRMY's Sales? Visit HRMY's Sales by Segment




Other Ratios
Harmony Biosciences Holdings Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
HRMY's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for HRMY's Competitors
Revenue per Employee for HRMY's Suppliers
Revenue per Employee for HRMY's Customers

You may also want to know
HRMY's Sales Growth Rates HRMY's Pe Price to earnings ratio HRMY's Receivables Turnover Ratio HRMY's Stock Quote
HRMY's Net Income Growth Rates HRMY's Ps Price to Sales ratio HRMY's Sales per Employee HRMY's Asset Turnover Ratio
HRMY's Net Margin HRMY's Pb Price to Book ratio HRMY's Financial Strength Ratios HRMY's Dividend Payout Ratio
Date modified: 2026-08-30T20:51:22+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Xeris Biopharma Holdings Inc   5,160,215.38 $ 335.414  Million 65 
P3 Health Partners Inc   4,696,368.75 $ 1,502.838  Million 320 
Nuvation Bio Inc   3,943,046.51 $ 169.551  Million 43 
Halozyme Therapeutics Inc   3,933,186.76 $ 1,663.738  Million 423 
Ironwood Pharmaceuticals inc   3,893,160.00 $ 389.316  Million 100 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.